Creator Profile
Martin Shkreli
YouTube | Stock
92,700 followers
Visit creator profileReturn Since February 25, 2026
Recent Posts
Latest published research
April 6, 2026
4/6/26 - sorry for the wait!
Martin Shkreli returns after an illness, discussing various topics including biotech deals, drug development, and personal health regimens. He touches on Seleno acquisition by Nurocran, Lightwave Logic, Amgen's execution, and mentions Biogen and Viatris with some commentary.
March 20, 2026
3/20/26 - sorry for the wait!
The creator discusses several companies including Super Micro, Planet Labs, Moderna, Denali, and Arrowhead. He expresses surprise at Super Micro's stock drop, notes Planet Labs' record revenue, and highlights Arrowhead as a significant past winner and Surreptit's partner.
February 25, 2026
2/25/26 - NVDA earnings release
Dry-run Step 5 insert for NVDA
Recent Stock Calls
Only high-conviction signal-backed calls appear here, so newer research posts can stay commentary-only.
High-Conviction Portfolio Performance Since February 25, 2026
Shows only high-conviction calls in the selected time window.
0
Locked
Locked
Unlock full creator track record
Premium unlocks creator performance analytics, benchmark comparisons, and the historical signal table.
Ticker Signal History
Unlock ticker signal history
Premium unlocks the creator's full ticker timeline, including bullish, bearish, and research-only events with dates.
Industry Allocation
Unlock sector allocation
Sector concentration is part of the premium creator profile.